论文部分内容阅读
自Ｔｉｌｎｅｙ等在 1 973年首次命名多器官衰竭 (ｍｕｌｔｉｐｌｅｏｒｇａｎｆａｉｌｕｒｅ ,ＭＯＦ)至今 ,有关ＭＯＦ的实验研究与临床治疗取得了许多进展 ,但在降低其发生率和病死率方面 ,仍未有重要突破[1 ] 。近年来学者们渐以多器官功能不全综合征 (ｍｕｌｔｉｐｌｅｏ
Since Tilney et al. First named multipleorganfailure (MOF) in 1973, there have been many advances in experimental research and clinical treatment of MOF, but there are still no major breakthroughs in reducing its incidence and mortality [1 ]. In recent years, scholars gradually developed multiple organ dysfunction syndrome (multipleo